Masimo Stock Forecast, Price & News

Masimo (NASDAQ:MASI) Frequently Asked Questions

Is Masimo a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Masimo stock.
View analyst ratings for Masimo or view top-rated stocks.

What stocks does MarketBeat like better than Masimo?

Wall Street analysts have given Masimo a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Masimo wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Masimo's next earnings date?

Masimo is scheduled to release its next quarterly earnings announcement on Tuesday, October 26th 2021.
View our earnings forecast for Masimo.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) posted its quarterly earnings data on Monday, July, 26th. The medical equipment provider reported $0.94 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.04. The medical equipment provider had revenue of $300.78 million for the quarter, compared to analyst estimates of $295.60 million. Masimo had a trailing twelve-month return on equity of 15.17% and a net margin of 19.00%. The business's revenue was down .1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.85 earnings per share.
View Masimo's earnings history.

How has Masimo's stock been impacted by Coronavirus (COVID-19)?

Masimo's stock was trading at $182.64 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MASI shares have increased by 52.8% and is now trading at $279.00.
View which stocks have been most impacted by COVID-19.

What guidance has Masimo issued on next quarter's earnings?

Masimo issued an update on its FY 2021 earnings guidance on Tuesday, August, 3rd. The company provided earnings per share (EPS) guidance of $3.850-$3.850 for the period, compared to the Thomson Reuters consensus estimate of $3.770. The company issued revenue guidance of $1.22 billion-$1.22 billion, compared to the consensus revenue estimate of $1.21 billion.

What price target have analysts set for MASI?

5 equities research analysts have issued 1-year price objectives for Masimo's shares. Their forecasts range from $276.00 to $310.00. On average, they anticipate Masimo's stock price to reach $292.75 in the next twelve months. This suggests a possible upside of 4.9% from the stock's current price.
View analysts' price targets for Masimo or view top-rated stocks among Wall Street analysts.

Who are Masimo's key executives?

Masimo's management team includes the following people:

• Joe E. Kiani, Chairman & Chief Executive Officer
• Bilal Muhsin, Chief Operating Officer
• Micah Young, Chief Financial Officer & Executive Vice President
• Yongsam Lee, Chief Information Officer & Executive VP
• Anand Sampath, Executive VP-Operations & Clinical Research

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo CEO Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among Masimo's employees.

Who are some of Masimo's key competitors?

Some companies that are related to Masimo include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Edwards Lifesciences (EW), Becton, Dickinson and (BDX), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), Baxter International (BAX), ResMed (RMD), STERIS (STE), Insulet (PODD), Hologic (HOLX) and Teleflex (TFX).
View all of MASI's competitors.

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), The Trade Desk (TTD), The Walt Disney (DIS) and Twilio (TWLO).

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Who are Masimo's major shareholders?

Masimo's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (16.20%), Vanguard Group Inc. (8.52%), FMR LLC (3.78%), Ownership Capital B.V. (3.52%), State Street Corp (3.09%) and Invesco Ltd. (2.09%). Company insiders that own Masimo stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee.
View institutional ownership trends for Masimo.

Which major investors are selling Masimo stock?

MASI stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., FMR LLC, Massachusetts Financial Services Co. MA, Neuberger Berman Group LLC, First Trust Advisors LP, State of Michigan Retirement System, Swiss National Bank, and Wells Fargo & Company MN. Company insiders that have sold Masimo company stock in the last year include Anand Sampath, Bilal Muhsin, Craig B Reynolds, Joe E Kiani, Micah W Young, and Thomas Samuel Mcclenahan.
View insider buying and selling activity for Masimo or view top insider-selling stocks.

Which major investors are buying Masimo stock?

MASI stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Macquarie Group Ltd., Korea Investment CORP, RTW Investments LP, Vaughan Nelson Investment Management L.P., Champlain Investment Partners LLC, Ensemble Capital Management LLC, and Citigroup Inc..
View insider buying and selling activity for Masimo or or view top insider-buying stocks.

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $279.00.

How much money does Masimo make?

Masimo has a market capitalization of $15.36 billion and generates $1.14 billion in revenue each year. The medical equipment provider earns $240.30 million in net income (profit) each year or $3.60 on an earnings per share basis.

How many employees does Masimo have?

Masimo employs 5,300 workers across the globe.

When was Masimo founded?

Masimo was founded in 1989.

What is Masimo's official website?

The official website for Masimo is www.masimo.com.

Where are Masimo's headquarters?

Masimo is headquartered at 52 DISCOVERY, IRVINE CA, 92618.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at (949) 297-7000 or via email at [email protected].